Covered recipient · General Payments record
RONALD B SITES
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2022
$1,812.52
- Reported across 116 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $301.89 | 18 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $181.19 | 12 |
| Janssen Pharmaceuticals, Inc | $67.41 | 3 |
| Alkermes, Inc. | $19.86 | 1 |
| Corium, Inc. | $17.51 | 1 |
| Neos Therapeutics, LP | $15.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.08 | 02/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891618259 | CMS |
| ABBVIE INC. | $13.08 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891618261 | CMS |
| ABBVIE INC. | $15.35 | 04/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891618263 | CMS |
| ABBVIE INC. | $26.13 | 05/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891618265 | CMS |
| ABBVIE INC. | $20.14 | 05/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891618267 | CMS |
| ABBVIE INC. | $18.30 | 06/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891618269 | CMS |
| ABBVIE INC. | $10.62 | 07/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891618271 | CMS |
| ABBVIE INC. | $3.58 | 08/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891618273 | CMS |
| ABBVIE INC. | $11.10 | 08/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891618275 | CMS |
| ABBVIE INC. | $12.49 | 10/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891618277 | CMS |
| ABBVIE INC. | $14.86 | 10/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891618279 | CMS |
| ABBVIE INC. | $20.46 | 11/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891618281 | CMS |
| Alkermes, Inc. | $19.86 | 03/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 925945679 | CMS |
| Corium, LLC | $17.51 | 01/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 924817171 | CMS |
| Janssen Pharmaceuticals, Inc | $21.63 | 02/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886095759 | CMS |
| Janssen Pharmaceuticals, Inc | $23.83 | 07/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886095753 | CMS |
| Janssen Pharmaceuticals, Inc | $21.95 | 10/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886095747 | CMS |
| Neos Therapeutics, LP | $15.92 | 04/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893138923 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.